- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07623746
Neural Mechanisms of Emotion-behaviour Interactions (EMOBB)
Neural and Cognitive Mechanism of Adaptive and Maladaptive Interplay Between Emotions in Behaviour in Naturalistic Tasks
Deciding what to do when for how long - self-organizing one's behaviour - is an important feature of daily life. Emotions arise providing short-cuts for the computational complexities. Yet, one still knows relatively little about the underlying cognitive and neural mechanisms. EMOBB will establish the computational, cognitive and neural underpinnings of the rich interplay between emotions and self-organized behaviour in naturalistic environments. Previous work has almost exclusively relied on tasks structured into experimenter determined trials - thus how people self-organized behaviour could not be measured. To overcome this, EMOBB will combine novel naturalistic tasks in which people have freedom what to do when for how long with subjective and objective measurements of emotions. This will be made possible through a computational modelling approach that allows dissecting and quantifying even complex behaviour-emotion interactions.
Specifically, EMOBB will use three cognitive tasks of emotion-behaviour interplay that participants will do while undergoing functional magnetic resonance brain imaging and monitoring of their facial expressions with an MRI-compatible camera.
The primary hypothesis of EMOBB is that both unique and shared neural networks will underpin the interplay between emotions and behaviour across our cognitive tasks.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Jacqueline SCHOLL, PhD
- Phone Number: 4 81 10 65 00 + 33
- Email: jacqueline.scholl@inserm.fr
Study Locations
-
-
-
Bron, France, 69500
- CERMEP (Centre d'Etude de Recherche Multimodal et pluridisciplinaire en imagerie du vivant)
-
Contact:
- Jacqueline SCHOLL, PhD
- Phone Number: + 33 4 81 10 65 00
- Email: jacqueline.scholl@inserm.fr
-
Principal Investigator:
- Jacqueline SCHOLL, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18-45 years old,
- fluent French speakers,
- healthy,
- without a beard at the time of testing,
- right-handed,
- being able to use both hands
- BMI between 18.5 and 30
- give written informed consen
- for women: contraception;
Exclusion Criteria:
- neurological, psychiatric disorders, or severe chronic disorders (diabetes, cardiac, kidney, lung, liver disorders, inflammatory disorders)
- pregnancy or breast-feeding
- under guardianship, currently admitted to a psychiatric hospital other than for research purposes)
- not wanting to be informed of abnormalities detected during MRI scan,
- taking part in other studies with exclusion periods,
- MRI exclusion criteria (cardiac pace maker etc, vascular or intracranial clamps or stents, neurological stimulator, any other metal in the body, past accidents with metal to the eyes, metallic prostheses, metal in the mouth (braces, retainers), medication pumps, any implants (e.g. hearing implants), piercings that cannot be removed, having worked with metal (other than radiography related to MRI) being claustrophobic, tatoos above the shoulders.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Task 1: self-organization under threat
|
Participants will perform a cognitive task (responses through button presses) while we measure brain activity with functional magnetic resonance imaging (fMRI) and record their facial expressions.
|
|
Experimental: Task 2: self-organization and learning
|
Participants will perform a cognitive task (responses through button presses) while we measure brain activity with functional magnetic resonance imaging (fMRI) and record their facial expressions.
|
|
Experimental: Task 3 : self-organization and social context
|
Participants will perform a cognitive task (responses through button presses) while we measure brain activity with functional magnetic resonance imaging (fMRI) and record their facial expressions.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brain activity in regions of interest
Time Frame: Day 0
|
Brain activity is captured as percentage change in blood-oxygen-level-dependent (BOLD) signal with FMRI compared to baseline across tasks across brain regions (ventromedial prefrontal cortex, vmPFC; dorsal anterior cingulate cortex, dACC).
|
Day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Brain activity during task 1 (Self-organization under threat)
Time Frame: Day 0
|
Brain activity is captured as percentage change in blood-oxygen-level-dependent (BOLD) signal with FMRI compared to rest in task 1 across brain regions (ventromedial prefrontal cortex, vmPFC; dorsal anterior cingulate cortex, dACC).
|
Day 0
|
|
Brain activity during task 2 (Self-organization and learning)
Time Frame: Day 0
|
Brain activity is captured as percentage change in blood-oxygen-level-dependent (BOLD) compared to rest in task 2 across brain regions (ventromedial prefrontal cortex, vmPFC; dorsal anterior cingulate cortex, dACC).
|
Day 0
|
|
Brain activity during task 3 (Self-organization and social context)
Time Frame: Day 0
|
Brain activity is captured as percentage change in blood-oxygen-level-dependent (BOLD) signal with FMRI compared to rest in task 3 across brain regions (ventromedial prefrontal cortex, vmPFC; dorsal anterior cingulate cortex, dACC).
|
Day 0
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jacqueline SCHOLL, PhD, Institut National de la Santé Et de la Recherche Médicale, France
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 69HCL25_1123
- 2025-A02658-41 (Other Identifier: ID-RCB)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy Volunteer
-
University Magna GraeciaNot yet recruitingHealthy Volunteer | Healthy Volunteer StudyItaly
-
National Heart, Lung, and Blood Institute (NHLBI)TerminatedHealthy | Healthy Volunteer | HVUnited States
-
AbbVieNot yet recruiting
-
TrueLab Biopharmaceutical Co., LtdSAPRO Consulting Pty LtdRecruiting
-
Aspargo Labs, IncNot yet recruitingHealthy Volunteer
-
Aspargo Labs, IncNot yet recruiting
-
Aspargo Labs, IncNot yet recruiting
-
AbbVieRecruitingHealthy VolunteerUnited States
-
Johns Hopkins UniversityRecruitingHealthy VolunteerUnited States
-
PfizerRecruitingHealthy VolunteerUnited States
Clinical Trials on Functional Magnetic Resonance Imaging (fMRI)
-
University Hospital, GrenobleCompleted
-
Centre Hospitalier Universitaire de Saint EtienneUniversity Hospital of Saint-EtienneCompleted
-
Centre Hospitalier Universitaire de Saint EtienneTerminatedMagnetic Resonance Imaging | Neuronal ActivityFrance
-
University of MichiganCompletedHealthy ParticipantsUnited States
-
Massachusetts General HospitalBrain & Behavior Research FoundationCompletedBipolar Disorder | Major Depression | RuminationUnited States
-
Lykos TherapeuticsCompleted
-
Maastricht University Medical CenterTerminatedChronic Obstructive Pulmonary Disease | Pancreatic Cancer | Cachexia | Non-small Cell Lung CancerNetherlands
-
University of California, IrvineWithdrawnMild Traumatic Brain InjuryUnited States
-
University Hospital, ToulouseCompleted
-
University Hospital, GrenobleLaboratoire de Psychologie et NeuroCognitionTerminated